11 – 20 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
-
Mark
How to assess breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
- 2020
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
(
- Contribution to journal › Article
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
The Swedish National Airway Register (SNAR) : development, design and utility to date
(
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
(
- Contribution to journal › Article